Implementation of a clinic policy of client-regulated methadone dosing

Elias Robles-Sotelo, Forrest B. Miller, Karen K. Gilmore-Thomas, Donald E. McMillan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

A six-month interval (baseline) during which methadone doses above 99 mg required individual approval by the clinic's physician was compared with the subsequent 16-month period in which a policy of patient-regulated methadone dosing with no preset upper limit was implemented. During the later phase, all patients were required to remain at each selected dose for a minimum of four days, and standard compliance-based take-home dosing procedures were followed. For patients in the study sample (n=57), the daily maximum methadone dose increased from 165 mg during baseline to 300 mg during the self-regulation period, while their average daily methadone dose increased from 76.84 mg to 80.04 mg (W=473, n=57, p=0.01). Monthly percent of opiate-positive urine specimens decreased significantly from 5.26% during baseline to 1.64% during the self-regulated dose period (W=169, n=57, p<0.01), and use of other drugs remained unchanged. No patient failed to show possession of recalled take-home doses, and no instances of liquid methadone diversion were reported by law enforcement agencies in the area.

Original languageEnglish (US)
Pages (from-to)225-230
Number of pages6
JournalJournal of Substance Abuse Treatment
Volume20
Issue number3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Methadone
Opiate Alkaloids
Law Enforcement
Compliance
Urine
Physicians
Pharmaceutical Preparations

Keywords

  • Dosing
  • Methadone
  • Opiates
  • Self-regulation
  • Titration

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Implementation of a clinic policy of client-regulated methadone dosing. / Robles-Sotelo, Elias; Miller, Forrest B.; Gilmore-Thomas, Karen K.; McMillan, Donald E.

In: Journal of Substance Abuse Treatment, Vol. 20, No. 3, 2001, p. 225-230.

Research output: Contribution to journalArticle

Robles-Sotelo, Elias ; Miller, Forrest B. ; Gilmore-Thomas, Karen K. ; McMillan, Donald E. / Implementation of a clinic policy of client-regulated methadone dosing. In: Journal of Substance Abuse Treatment. 2001 ; Vol. 20, No. 3. pp. 225-230.
@article{dfd54d57ca75405cba81de352688b0dc,
title = "Implementation of a clinic policy of client-regulated methadone dosing",
abstract = "A six-month interval (baseline) during which methadone doses above 99 mg required individual approval by the clinic's physician was compared with the subsequent 16-month period in which a policy of patient-regulated methadone dosing with no preset upper limit was implemented. During the later phase, all patients were required to remain at each selected dose for a minimum of four days, and standard compliance-based take-home dosing procedures were followed. For patients in the study sample (n=57), the daily maximum methadone dose increased from 165 mg during baseline to 300 mg during the self-regulation period, while their average daily methadone dose increased from 76.84 mg to 80.04 mg (W=473, n=57, p=0.01). Monthly percent of opiate-positive urine specimens decreased significantly from 5.26{\%} during baseline to 1.64{\%} during the self-regulated dose period (W=169, n=57, p<0.01), and use of other drugs remained unchanged. No patient failed to show possession of recalled take-home doses, and no instances of liquid methadone diversion were reported by law enforcement agencies in the area.",
keywords = "Dosing, Methadone, Opiates, Self-regulation, Titration",
author = "Elias Robles-Sotelo and Miller, {Forrest B.} and Gilmore-Thomas, {Karen K.} and McMillan, {Donald E.}",
year = "2001",
doi = "10.1016/S0740-5472(00)00168-9",
language = "English (US)",
volume = "20",
pages = "225--230",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Implementation of a clinic policy of client-regulated methadone dosing

AU - Robles-Sotelo, Elias

AU - Miller, Forrest B.

AU - Gilmore-Thomas, Karen K.

AU - McMillan, Donald E.

PY - 2001

Y1 - 2001

N2 - A six-month interval (baseline) during which methadone doses above 99 mg required individual approval by the clinic's physician was compared with the subsequent 16-month period in which a policy of patient-regulated methadone dosing with no preset upper limit was implemented. During the later phase, all patients were required to remain at each selected dose for a minimum of four days, and standard compliance-based take-home dosing procedures were followed. For patients in the study sample (n=57), the daily maximum methadone dose increased from 165 mg during baseline to 300 mg during the self-regulation period, while their average daily methadone dose increased from 76.84 mg to 80.04 mg (W=473, n=57, p=0.01). Monthly percent of opiate-positive urine specimens decreased significantly from 5.26% during baseline to 1.64% during the self-regulated dose period (W=169, n=57, p<0.01), and use of other drugs remained unchanged. No patient failed to show possession of recalled take-home doses, and no instances of liquid methadone diversion were reported by law enforcement agencies in the area.

AB - A six-month interval (baseline) during which methadone doses above 99 mg required individual approval by the clinic's physician was compared with the subsequent 16-month period in which a policy of patient-regulated methadone dosing with no preset upper limit was implemented. During the later phase, all patients were required to remain at each selected dose for a minimum of four days, and standard compliance-based take-home dosing procedures were followed. For patients in the study sample (n=57), the daily maximum methadone dose increased from 165 mg during baseline to 300 mg during the self-regulation period, while their average daily methadone dose increased from 76.84 mg to 80.04 mg (W=473, n=57, p=0.01). Monthly percent of opiate-positive urine specimens decreased significantly from 5.26% during baseline to 1.64% during the self-regulated dose period (W=169, n=57, p<0.01), and use of other drugs remained unchanged. No patient failed to show possession of recalled take-home doses, and no instances of liquid methadone diversion were reported by law enforcement agencies in the area.

KW - Dosing

KW - Methadone

KW - Opiates

KW - Self-regulation

KW - Titration

UR - http://www.scopus.com/inward/record.url?scp=0034980292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034980292&partnerID=8YFLogxK

U2 - 10.1016/S0740-5472(00)00168-9

DO - 10.1016/S0740-5472(00)00168-9

M3 - Article

VL - 20

SP - 225

EP - 230

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

IS - 3

ER -